TIAA Report Asks Choice

WASHINGTON—A draft report on the nation’s largest teachers’ pension system recommends a variety of new investment choices for its policyholders—but still may not silence its swelling chorus of critics. The report by a special trustee committee of the Teachers Insurance and Annuity Association-College Retirement Equities Fund (TIAA-CREF) calls for adding six pension funds to the $63 billion system. More than 1 million policyholders have joined the system in plans offere

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WASHINGTON—A draft report on the nation’s largest teachers’ pension system recommends a variety of new investment choices for its policyholders—but still may not silence its swelling chorus of critics.

The report by a special trustee committee of the Teachers Insurance and Annuity Association-College Retirement Equities Fund (TIAA-CREF) calls for adding six pension funds to the $63 billion system. More than 1 million policyholders have joined the system in plans offered by some 3,800 colleges, universities, independent schools and nonprofit research institutions.

Current policyholders have been limited to the TIAA fixed annuity fund and the CREF equity fund, although a money market fund will soon be added. The small number of choices and the lack of transferability between funds have drawn much criticism. The new options recommended in the report include adding a second fixed annuity fund to TIAA and five variable annuity funds—including a bond fund and several equities funds—to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies